Milk osteopontin alters the infant microbiome to drive DC hematopoiesis and disease tolerance

Summary

Research demonstrates that milk-derived osteopontin protects infants from severe lower respiratory infections by modifying the neonatal gut microbiome and promoting dendritic cell hematopoiesis. This is a preclinical scientific finding without regulatory or clinical trial data.